These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36388269)

  • 1. Clinical significance of novel biomarkers to predict the natural course of hepatitis B infection.
    Wu W; Yuan X; Zhang W; Zhou H; Kong X; He Z; Fu T; Zhang W; Jia W; Liang C; Tang H; Wang F; Ye Y; Shao Z; Ji Z
    Front Public Health; 2022; 10():1037508. PubMed ID: 36388269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection.
    Gou Y; Zhao Y; Rao C; Feng S; Wang T; Li D; Tao C
    Clin Lab; 2017 Jul; 63(7):1063-1070. PubMed ID: 28792701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
    Ghany MG; King WC; Lisker-Melman M; Lok ASF; Terrault N; Janssen HLA; Khalili M; Chung RT; Lee WM; Lau DTY; Cloherty GA; Sterling RK
    Hepatology; 2021 Nov; 74(5):2395-2409. PubMed ID: 34133774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.
    Maasoumy B; Wiegand SB; Jaroszewicz J; Bremer B; Lehmann P; Deterding K; Taranta A; Manns MP; Wedemeyer H; Glebe D; Cornberg M
    Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linearized hepatitis B surface antigen and hepatitis B core-related antigen in the natural history of chronic hepatitis B.
    Seto WK; Wong DK; Fung J; Huang FY; Liu KS; Lai CL; Yuen MF
    Clin Microbiol Infect; 2014 Nov; 20(11):1173-80. PubMed ID: 24975365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critique and systematic review of the clinical utility of hepatitis B core-related antigen.
    Adraneda C; Tan YC; Yeo EJ; Kew GS; Khakpoor A; Lim SG
    J Hepatol; 2023 Apr; 78(4):731-741. PubMed ID: 36586590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct patterns of serum hepatitis B core-related antigen during the natural history of chronic hepatitis B.
    Zhang ZQ; Zhang XN; Lu W; Wang YB; Weng QC; Feng YL
    BMC Gastroenterol; 2017 Dec; 17(1):140. PubMed ID: 29202690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of HBV RNA and to predict change in serological status and disease activity in CHB.
    Ghany MG; King WC; Hinerman AS; Lok AS; Lisker-Melman M; Chung RT; Terrault N; Janssen HLA; Khalili M; Lee WM; Lau DTY; Cloherty GA; Sterling RK
    Hepatology; 2023 Nov; 78(5):1542-1557. PubMed ID: 37074026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients.
    Li J; Wu Z; Wang GQ; Zhao H
    Chin Med J (Engl); 2021 Mar; 134(10):1160-1167. PubMed ID: 33734135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B core-related antigen serum levels may be a predictor of acute flare of chronic hepatitis B among pregnant women in the immune-tolerant phase of chronic HBV infection after short-course antiviral therapy.
    Liu R; Yang L; Jiang T; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hao H; Hu L; Gao Y; Xu M; Chen X; Yi W; Li M; Xie Y
    Virulence; 2023 Dec; 14(1):2186335. PubMed ID: 36864005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.
    van Campenhout MJH; Rijckborst V; Brouwer WP; van Oord GW; Ferenci P; Tabak F; Akdogan M; Pinarbasi B; Simon K; de Knegt RJ; Boonstra A; Janssen HLA; Hansen BE
    J Viral Hepat; 2019 Oct; 26(10):1156-1163. PubMed ID: 31135084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy.
    Mak LY; Cloherty G; Wong DK; Gersch J; Seto WK; Fung J; Yuen MF
    Hepatology; 2021 Jun; 73(6):2167-2179. PubMed ID: 33159329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients.
    Brakenhoff SM; de Knegt RJ; van Campenhout MJH; van der Eijk AA; Brouwer WP; van Bömmel F; Boonstra A; Hansen BE; Berg T; Janssen HLA; de Man RA; Sonneveld MJ
    J Microbiol Immunol Infect; 2023 Feb; 56(1):31-39. PubMed ID: 35941076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of hepatitis B virus core-related antigen to evaluate natural history of chronic hepatitis B.
    Chan HLY; Yasuda S; Wong GLH; Tada T; Chan CKM; Kumada T; Tse YK; Wong VWS; Toyoda H
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2202-2209. PubMed ID: 32293740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
    Carey I; Gersch J; Wang B; Moigboi C; Kuhns M; Cloherty G; Dusheiko G; Agarwal K
    Hepatology; 2020 Jul; 72(1):42-57. PubMed ID: 31701544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy.
    Liao H; Liu Y; Li X; Wang J; Chen X; Zou J; Li Q; Liu L; Wang J; Huang B; Lu F; Xu D
    Antivir Ther; 2019; 24(2):105-115. PubMed ID: 30511941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia.
    Lisker-Melman M; King WC; Ghany MG; Chung RT; Hinerman AS; Cloherty GA; Khalili M; Jain MK; Sulkowski M; Sterling RK
    J Viral Hepat; 2023 Aug; 30(8):700-709. PubMed ID: 37278302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.